The US diabetic retinopathy market is witnessing steady growth due to the increasing prevalence of diabetes, strong adoption of advanced retinal imaging technologies, and well-established ophthalmology care infrastructure. Rising awareness of early eye screening, expanding use of innovative therapies, and continuous investments in diabetes management are driving market expansion. The presence...